Back

Natrurietic peptide-guided therapy: a curvy road ahead.

1 May 2017 (14:15 - 14:33)
Organised by:
Congress Presentation Part of: Biomarkers in chronic heart failure Biomarkers HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Mark Richards

University of Otago Christchurch, Christchurch (New Zealand)

4 More presentations in this session

Presentation thumbnail
New markers of acute kidney injury.
Doctor M. Costanzo (Naperville, US)
Slides Video
Presentation thumbnail
Long term outcome: ST-2 and/or adrenomedulin.
Professor H. Brunner-La Rocca (Maastricht, NL)
Slides Video
Presentation thumbnail
What is in the pipeline?
Professor A. Maisel (San Diego, US)
Slides Video
Presentation thumbnail
Biomarkers changed my daily practice!
Professor R. De Boer (Rotterdam, NL)
Slides Video

Access the full session

Session thumbnail
Biomarkers in chronic heart failure

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Clinical effects and safety of NT-proBNP-guided therapy in patients hospitalized for acute decompensated heart failure.
29 June 2021
thumbnail
Congress Session
Advances in medical therapy in heart failure
20 May 2025
thumbnail
Congress Presentation
C-type natriuretic peptide attenuates diastolic dysfunction and cardiac fibrosis in a rat model of heart failure with preserved ejection fraction
28 August 2026
thumbnail
Congress Presentation
State-of-the-art lecture on current state of the diagnosis of heart failure
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources